Pfizer Buys Into Brazil

Pfizer Buys Into Brazil

Brazil M&A

Pfizer has agreed to acquire a 40% stake in Brazilian genetic pharmaceutical company Laboratorio Teuto Brasileiro, with an option to take the rest starting in 2014. Pfizer will make an upfront payment of BRL400m and Teuto will be eligible to receive a performance-based milestone payment. "Teuto's partnership with Pfizer is very complementary to our business goals," says Teuto CEO Marcelo Henriques. “It will expand our product portfolio and address the needs of the changing customer base.” Accord

Already have an account?

Free trial

Take a free two-week trial now for the latest news, data and market analysis.

Free Trial